Paper29056830
Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression.
Fu X and 9 others. Mediators Inflamm, 2017. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression. Papers, record 29056830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29056830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colitis | Major topic |
| Dextran Sulfate | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Piperidines | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| TOR Serine-Threonine Kinases | Major topic |
| Animals | |
| Apoptosis | |
| Cell Line | |
| Disease Models, Animal | |
| Flow Cytometry | |
| Humans | |
| Jurkat Cells | |
| Mice | |
| Quinolizidines | |
| Signal Transduction |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11514607 | Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. | J Exp Med | 2001 | https://conductscience.org/library/papers/11514607 | PubMed |
| 2 | 12423274 | Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. | J Gastroenterol Hepatol | 2002 | https://conductscience.org/library/papers/12423274 | PubMed |
| 3 | 16051150 | An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. | Cell | 2005 | https://conductscience.org/library/papers/16051150 | PubMed |
| 4 | 16648838 | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. | Nature | 2006 | https://conductscience.org/library/papers/16648838 | PubMed |
| 5 | 17086192 | Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. | Nature | 2007 | https://conductscience.org/library/papers/17086192 | PubMed |
| 6 | 17726744 | Induction of experimental acute ulcerative colitis in rats by administration of dextran sulfate sodium at low concentration followed by intracolonic administration of 30% ethanol. | J Zhejiang Univ Sci B | 2007 | https://conductscience.org/library/papers/17726744 | PubMed |
| 7 | 18755808 | Hyperosmotic stress contributes to mouse colonic inflammation through the methylation of protein phosphatase 2A. | Am J Physiol Gastrointest Liver Physiol | 2008 | https://conductscience.org/library/papers/18755808 | PubMed |
| 8 | 18848473 | The TSC-mTOR signaling pathway regulates the innate inflammatory response. | Immunity | 2008 | https://conductscience.org/library/papers/18848473 | PubMed |
| 9 | 19390566 | Immunoregulatory functions of mTOR inhibition. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19390566 | PubMed |
| 10 | 20182580 | Physiological regulation of Akt activity and stability. | Am J Transl Res | 2010 | https://conductscience.org/library/papers/20182580 | PubMed |
| 11 | 20387224 | Total alkaloids of Sophora alopecuroides increases the expression of CD4+ CD25+ Tregs and IL-10 in rats with experimental colitis. | Am J Chin Med | 2010 | https://conductscience.org/library/papers/20387224 | PubMed |
| 12 | 20465569 | Generation, persistence and plasticity of CD4 T-cell memories. | Immunology | 2010 | https://conductscience.org/library/papers/20465569 | PubMed |
| 13 | 21155568 | Five bitter compounds display different anti-inflammatory effects through modulating cytokine secretion using mouse primary splenocytes in vitro. | J Agric Food Chem | 2011 | https://conductscience.org/library/papers/21155568 | PubMed |
| 14 | 21371468 | Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. | Eur J Pharmacol | 2011 | https://conductscience.org/library/papers/21371468 | PubMed |
| 15 | 21419339 | Inhibition of protein phosphatase 2A activity by PI3Kγ regulates β-adrenergic receptor function. | Mol Cell | 2011 | https://conductscience.org/library/papers/21419339 | PubMed |
| 16 | 21488902 | Regulatory T cells and Foxp3. | Immunol Rev | 2011 | https://conductscience.org/library/papers/21488902 | PubMed |
| 17 | 21531892 | Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. | J Immunol | 2011 | https://conductscience.org/library/papers/21531892 | PubMed |
| 18 | 21670230 | Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury. | Circulation | 2011 | https://conductscience.org/library/papers/21670230 | PubMed |
| 19 | 22517423 | Regulation and function of mTOR signalling in T cell fate decisions. | Nat Rev Immunol | 2012 | https://conductscience.org/library/papers/22517423 | PubMed |
| 20 | 22796409 | Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. | Am J Pathol | 2012 | https://conductscience.org/library/papers/22796409 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942819 | A Mesalazine-Aloperine Co-Amorphous System for Simultaneous Dissolution Enhancement, Permeability Improvement, and Synergistic Anti-Ulcerative Colitis Activity: A Combined Pharmaceutics and Network Pharmacology Study. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942819 | PubMed |
| 42352257 | Aloperine Suppresses the Tumorigenicity of Esophageal Squamous Cell Carcinoma by Targeting the AP-1/IL-6/STAT3 Signaling Axis. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352257 | PubMed |
| 42152943 | Yi-qi-hua-yu-jie-du Decoction Inhibits Gastric Cancer Progression by Inducing Tumor-Associated Macrophage Polarization via Modulating PP2A Enzyme Activity to Mediate the PI3K/AKT/NF-κB Axis. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42152943 | PubMed |
| 41721353 | Aloperine alleviates LPS-induced inflammation in bovine intestinal epithelial cells through autophagy and TLR4/p38 MAPK/NF-κB pathway. | BMC Vet Res | 2026 | https://conductscience.org/library/papers/41721353 | PubMed |
| 41660626 | GDF15 orchestrates mitochondrial-immune crosstalk via SMAD7-HIF-1α-PKM2 cascade to attenuate septic liver injury. | Front Immunol | 2025 | https://conductscience.org/library/papers/41660626 | PubMed |
| 41633690 | [Xiezhuo Jiedu Recipe improves ulcerative colitis in rats by regulating Th17/Treg immune balance]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | https://conductscience.org/library/papers/41633690 | PubMed |
| 41116268 | Natural Product-based Therapies for Inflammatory Bowel Disease: Targeting Key Signaling Pathways. | Mini Rev Med Chem | 2025 | https://conductscience.org/library/papers/41116268 | PubMed |
| 40190330 | Aloperin improves liver non-alcoholic steatohepatitis in vitro and in vivo. | Arch Med Sci | 2025 | https://conductscience.org/library/papers/40190330 | PubMed |
| 39381066 | Aloperine Ameliorates Acetaminophen-Induced Acute Liver Injury through HMGB1/TLR4/NF-κB and NLRP3/Inflammasome Pathway. | Mediators Inflamm | 2024 | https://conductscience.org/library/papers/39381066 | PubMed |
| 39201769 | Aloperine Inhibits ASFV via Regulating PRLR/JAK2 Signaling Pathway In Vitro. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201769 | PubMed |
| 39166458 | Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome-lysosome Fusion in NSCLC. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39166458 | PubMed |
| 39054337 | The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasms. | Leukemia | 2024 | https://conductscience.org/library/papers/39054337 | PubMed |
| 37957143 | Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37957143 | PubMed |
| 37128338 | Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension. | Heliyon | 2023 | https://conductscience.org/library/papers/37128338 | PubMed |
| 36839389 | Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments. | Nutrients | 2023 | https://conductscience.org/library/papers/36839389 | PubMed |
| 36837836 | Callyspongia spp.: Secondary Metabolites, Pharmacological Activities, and Mechanisms. | Metabolites | 2023 | https://conductscience.org/library/papers/36837836 | PubMed |
| 36626227 | UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer. | J Clin Invest | 2023 | https://conductscience.org/library/papers/36626227 | PubMed |
| 36040377 | Arginine metabolism regulates the pathogenesis of inflammatory bowel disease. | Nutr Rev | 2023 | https://conductscience.org/library/papers/36040377 | PubMed |
| 35721119 | Aloperine Ameliorates IMQ-Induced Psoriasis by Attenuating Th17 Differentiation and Facilitating Their Conversion to Treg. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35721119 | PubMed |
| 35665742 | Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35665742 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29056830
GET https://conductscience.org/api/papers/v1/29056830/references?page=2